Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

“The 2024–2025 COVID vaccine, which was released last fall, is still recommended for everyone aged six months or over,” the ...

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...

New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get ...

New requirements for clinical testing of vaccines, announced this month, may delay the availability of shots that had ...

The FDA announced that it would only allow COVID-19 vaccinations for those 65 years of age and over and those with certain ...

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be ...